Following rigorous pre-clinical research, only a very select few molecules and therapeutics for cancer enter clinical trials for determination of safety and efficacy. Currently, there are promising trials underway for immunotherapies and treatments for rare cancers. There are also trials investigating personalized medicine to address drug resistance, efficacy, and adverse events. As technologies continue to advance, various trials examine the use of digital tools and artificial intelligence in the clinical setting. Coupled with advanced screening and diagnostic techniques for early detection, patients may be able to initiate treatment sooner for better outcomes.
This eBook explores some of the latest and most promising cancer clinical trials.
Download the FREE eBook compliments of Clinical Lab Manager